Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Manufacturing & Bioprocessing
Healthcare Data Platforms: Expert Tips on Integrating Digitalisation with Cell and Gene Manufacturing
Developers looking to integrate digitalisation approaches into their pipeline should ensure that they choose a sensible architecture, rather than simply automating for the sake of it.
Antibody & Protein Engineering
App Note: CAR-T: A Promising Cell Therapy for Cancer Treatment
This application note by Sino Biological explores the key steps involved in CAR-T production to provide insights into the challenges that may impede successful CAR-T therapy.
Drug Discovery & Development
NK Cell Therapies and Their Promising Possibilities
Considering the potential of natural killer (NK) cells as immunotherapies for cancer treatment and the various methods being utilised to overcome cancer cells' resistance to NK cells.
Stem Cell Therapy
Gene Knockout Mice in Disease Modelling
Over the past 50 years, rare disease research has paved the way for medical breakthroughs such as allogeneic stem cell transplantation. Other focuses have included the identification of potential drug targets by analysing cellular and molecular pathways.
Gene Therapy Development
Approved Gene Therapy Products Brought to Market Through the use of AI
Many of the biggest roadblocks in gene therapy development can be removed by tapping into longitudinal datasets facilitated by AI techniques and machine learning, tracking the real-world progress of clinical trial participants.
NextGen Therapeutics
The Bispecific Antibody Landscape
Key opinion leaders explore recent developments for bispecific antibodies, from new delivery technologies to the complexity of their pharmacokinetic profiles.
Drug Discovery & Development
Axion Biosystems: Antibody-dependent Cellular Cytotoxicity of Natural Killer Cells
Trastuzumab promotes natural killer cell activation through antibody-dependent cellular cytotoxicity (ADCC).
Drug Discovery & Development
Axion Biosystems: CAR T Cell Potency Assessment with 3D Cancer Spheroid Models
The solid tumor microenvironment poses a significant challenge to immune therapies like CART cells.
Drug Discovery & Development
Axion Biosystems: In vitro Potency Assays for Immune Cell-Mediated Killing with the Maestro Z
Immunotherapy harnesses the power of the innate and adaptive immune system in various ways to seek out and attack cancer.
Biomarkers & Precision Medicine
Axion Biosystems: Organoid Analysis Module
Robust organoid quantification and monitoring.
Drug Discovery & Development
Axion Biosystems: Quantifying NK-mediated Cytolysis of Glioblastoma in vitro with Maestro Z
Immunotherapy aims to harness and enhance the body’s immune system to fight cancer.
Immunotherapy (Non-Oncology)
Canopy Biosciences: nCounter® Host Response Panel for Infectious Disease Research
Understanding the complex relationship between a pathogen and host response is important to developing effective vaccines and therapeutics to fight infectious disease.